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Neuroﬁbromatosis type 1 can be severe and associated with progressive course and death. Although it
has been rarely reported, a subset of patients with neuroﬁbromatosis type 1 may develop interstitial lung
disease. However, no case of neuroﬁbrosarcoma and lung involvement together has been reported so far.
We report a case of a 45-year-old male who was previously diagnosed as having neuroﬁbromatosis type
1, 12 years later after the initial diagnosis he was histologically conﬁrmed to have malignant trans-
formation, and 3 years later he had associated diffuse lung damage.
Copyright © 2016 Turkish Society of Medical Oncology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neuroﬁbromatosis, a common neurocutaneous disorder, in-
cludes numerous different forms. Neuroﬁbromatosis type 1 (NF1),
also known as von Recklinghausen's disease, is the most common
type and accounts for at least 85 percent of patients.1
Plexiform neuroﬁbromas can undergo malignant trans-
formation to neuroﬁbrosarcomas (also called malignant peripheral
nerve sheath tumors, malignant schwannomas or neurogenic sar-
comas). The lifetime risk of malignant transformation is estimated
to be 5 percent.1 Neuroﬁbrosarcomas are aggressive and potentially
fatal malignancies that most often occur in adolescence and
adulthood. The ﬁrst presentation ofmalignant transformation often
is pain or rapid growth of a nodule within an existing plexiform
neuroﬁbroma.2
The literature suggests that 10%e20% of adult patients with
neuroﬁbromatosis have associated interstitial lung disease. Char-
acteristics of such involvement include bilateral lower lobe ﬁbrosis
and may include bullous and cystic changes in advanced cases.
However, no case of neuroﬁbrosarcoma complicated with multiple
bullae in lungs has been described previously.ncology, Gulhane School of
0 312 3044150.
aradurmus).
ty of Medical Oncology.
ical Oncology. Production and hos2. Case presentation
A 45-year-old male presented with a 12-year history of neuro-
ﬁbromatosis. He had been admitted to a hospital 12 years earlier for
a painful cervical mass. An excisional biopsy had been performed
that revealed a benign plexiform neuroﬁbroma and he had been
followed-up without any treatment.
When he registered in 2002, he complained of a mass over the
chest wall, occurring four months before the present hospital
admission. He had no constitutional symptoms such as weight
loss, fever or night sweats. A complete physical examination was
performed which revealed a painful soft tissue mass on the right
anterolateral chest wall and multiple, rubbery, well-deﬁned,
painless skin nodules over the skull, trunk and extremities, sug-
gestive of neuroﬁbromas. In addition, there were multiple, hy-
perpigmented, irregularly shaped macules over the back,
suggestive of cafe-au-lait spots, eight of which were larger than
15 mm, and both axillary and inguinal freckling were present.
Family members were also found to have features of segmental
neuroﬁbromatosis. Cafe-au-lait spots were observed in his father,
two of his brothers, and his daughter. These ﬁndings were
consistent with the diagnosis of neuroﬁbromatosis. Thoracic CT
scans demonstrated a 10 10 cm soft-tissue subcutaneous mass in
the right lateral chest wall and a 30  15 mm sized solid nodule on
the lateral pleural side of the right lung. Subsequent histological
examinations of the resected thoracic mass and nodule revealed a
malignant mesenchymal tumor and metastatic malignantting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Fig. 1. A chest radiograph showing widespread, thin-walled, bulky bullae with effusion
Fig. 3. Cellular fascicles of pleomorphic spindle cells of the malignant peripheral nerve
sheath tumor (Hematoxylin & Eosin staining, 100 magniﬁcation)
N. Karadurmus et al. / Journal of Oncological Sciences 2 (2016) 84e86 85schwannoma, respectively. Adjuvant chemotherapy was proposed
but the patient did not accept the treatment and was lost to
follow-up for several years.
In February 2005, he returned with a recurrent mass over the
chest wall. At the time of presentation, he was restless and expe-
rienced progressive weakness and dyspnea. His oxygen saturation,
measured by pulse oximetry, was 89%while breathing room air and
had severe tachypnea. Chest radiograph (Fig. 1) and computed
tomographic scan (Fig. 2) showed widespread, thin-walled, bulky
bullae bilaterally placed in lung parenchyma and the presence of aFig. 2. A computed tomographic scan showing diffuse lung damage15  15 cm sized, well-demarcated, solid mass on the anterolateral
chest wall. Pathologic examination of the resected mass revealed
ﬂeshy and opaque soft tissue tumor with white-tan surface and
hemorrhagic, necrotic focal areas, macroscopically. Microscopic
appearance of the tumor showed highly cellular, pleomorphic
Schwann cell-like spindle cells with prominent mitotic activity,
consisting of dense fascicles alternating with less cellular areas.
Tumor cells revealed focal and strong immunoreactivity for S-100
protein (Figs. 3 and 4). The pathological diagnosis was malignant
peripheral nerve sheath tumor. Ophthalmologic examination was
found normal and bone abnormalities like pseudarthrosis and
dysplasia were not present.and a mass on the anterolateral aspect of the right chest wall
Fig. 4. Focal and strong S-100 protein immunoreactivity of the tumor
cells. (Immunohistochemistry, 200 magniﬁcation)
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16 daily fractions of 300 cGy, administered ﬁve days per week),
three cycles of chemotherapy and underwent thoracic drainage
and pleurodesis for intractable pleural effusion. Unfortunately, he
died 3 months later because of the rapidly progressive course of
disease.
3. Discussion
The diagnostic criteria for NF1, developed by the National In-
stitutes of Health Consensus Conference in 1987 and updated in
1997, are based upon speciﬁc clinical features.3e5 The diagnostic
criteria aremet in a patientwho has at least two of the followings: 1)
Six or more cafe-au-lait macules larger than 5 mm in greatest
diameter in prepubertal individuals or larger than 15mm in greatest
diameter in postpubertal individuals, 2) Two ormore neuroﬁbromas
of any type or one or more plexiform neuroﬁbromas, 3) Freckling in
the axillary or inguinal regions, 4) Optic glioma, 5) Two or more
Lisch nodules (iris hamartomas), 6) A distinctive osseous lesion, such
as sphenoid dysplasia or thinning of the long bone cortex, with or
without pseudarthrosis, and 7) A ﬁrst-degree relative with type 1
neuroﬁbromatosis according to the above criteria. Four of these
diagnostic criteria were completely fulﬁlled in the present patient.NF patients have an increased potential for malignant trans-
formation. However, a few cases of neuroﬁbrosarcoma associated
with NF1 have so far been reportedworldwide.6,7 Additionally, lung
involvement in NF1 is very rare and only sporadic cases have been
reported in the literature.8e10 To our knowledge, no case of neu-
roﬁbrosarcoma and multiple bullae in lungs together, as present in
the case reported herein, has been reported till date. Interstitial
involvement of the lung, caused by bullae subsequently increasing
in size, progressively developed in the present case over the past 3
years. The result was diffuse parenchymal lung damage. It's
remarkable that he was a non-smoker and had never lived with
smokers.
In conclusion, the presence of NF1 complicated with malignant
transformation and bulky parenchymal bullae in lung together is
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